ScholarIQanswers from OpenAlex

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF

PaperCitations, authors & open-access status

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF have?

ScholarIQcitation count

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF has 206 citations in the OpenAlex counts ScholarIQ stores.

When was Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF published?

ScholarIQyear

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF has 2016 year in the ScholarIQ index.

What is the open-access status of Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF?

ScholarIQoa status

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF has hybrid oa status in the ScholarIQ index.

What is the DOI of Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF?

ScholarIQdoi

The DOI for Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF is on the source record.

What is the PMID of Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF?

ScholarIQpmid

The PMID for Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF is on the source record.

What is the OpenAlex record for Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF?

ScholarIQopenalex

The OpenAlex for Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial